Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Non-cash Items (2022 - 2025)

Lexaria Bioscience's Non-cash Items history spans 4 years, with the latest figure at $26625.0 for Q4 2025.

  • Quarterly results put Non-cash Items at $26625.0 for Q4 2025, down 74.85% from a year ago — trailing twelve months through Nov 2025 was $26625.0 (down 74.85% YoY), and the annual figure for FY2025 was $206.0, down 99.98%.
  • Non-cash Items for Q4 2025 was $26625.0 at Lexaria Bioscience, up from $206.0 in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $1.3 million in Q2 2025 to a low of $206.0 in Q3 2025.
  • The 4-year median for Non-cash Items is $105869.0 (2024), against an average of $369832.4.
  • The sharpest move saw Non-cash Items soared 26898.86% in 2024, then crashed 99.98% in 2025.
  • Year by year, Non-cash Items stood at $46375.0 in 2022, then decreased by 0.75% to $46025.0 in 2023, then skyrocketed by 130.02% to $105869.0 in 2024, then plummeted by 74.85% to $26625.0 in 2025.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $26625.0, $206.0, and $1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.